Literature DB >> 32974459

Case report: Synergetic effect of ischaemia and increased vagal tone inducing ventricular fibrillation in a patient with Brugada syndrome.

Sophie C H Van Malderen1,2, Carl J Schultz3,4, Luc Jordaens1.   

Abstract

BACKGROUND: Brugada syndrome (BS) is a hereditary channelopathy associated with syncope, malignant ventricular arrhythmia, and sudden cardiac death. Right ventricular ischaemia and BS have similar underlying substrates precipitating ventricular tachycardia or fibrillation (VF). CASE
SUMMARY: A 72-year-old woman with BS and a stenosis on the proximal right coronary artery received several subsequent implantable cardioverter-defibrillator shocks due to VF during an episode of extreme nausea with vomiting. DISCUSSION: This case report emphasizes on the synergetic effect of mild ischaemia and increased vagal tone on the substrate responsible for BS to create pathophysiological changes precipitating VF.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Shock; Brugada syndrome; Case report; Ischaemia; Myocardial infarction; Vagal tone; Ventricular arrhythmia

Year:  2020        PMID: 32974459      PMCID: PMC7501915          DOI: 10.1093/ehjcr/ytaa202

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


  14 in total

1.  Cellular basis for ST-segment changes observed during ischemia.

Authors:  José M Di Diego; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2003       Impact factor: 1.438

2.  Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome.

Authors:  Kevin Vernooy; Serge Sicouri; Robert Dumaine; Kui Hong; Antonio Oliva; Elena Burashnikov; Carl Timmermans; Tammo Delhaas; Harry J G M Crijns; Charles Antzelevitch; Luz-Maria Rodriguez; Ramon Brugada
Journal:  Heart Rhythm       Date:  2006-07-07       Impact factor: 6.343

3.  What role for autonomic dysfunction in Brugada Syndrome? Pathophysiological and prognostic implications.

Authors:  Thomas Wichter
Journal:  Europace       Date:  2008-05-07       Impact factor: 5.214

4.  Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia.

Authors:  A Lukas; C Antzelevitch
Journal:  Cardiovasc Res       Date:  1996-09       Impact factor: 10.787

5.  I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium.

Authors:  J M Di Diego; Z Q Sun; C Antzelevitch
Journal:  Am J Physiol       Date:  1996-08

6.  Prolonged Right Ventricular Ejection Delay in Brugada Syndrome Depends on the Type of SCN5A Variant - Electromechanical Coupling Through Tissue Velocity Imaging as a Bridge Between Genotyping and Phenotyping.

Authors:  Sophie C H Van Malderen; Dorien Daneels; Dirk Kerkhove; Uschi Peeters; Dominic A M J Theuns; Steven Droogmans; Guy Van Camp; Caroline Weytjens; Martine Biervliet; Maryse Bonduelle; Sonia Van Dooren; Pedro Brugada
Journal:  Circ J       Date:  2017-08-04       Impact factor: 2.993

7.  Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences.

Authors:  José M Di Diego; Jeffrey M Fish; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2005-10       Impact factor: 1.438

8.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors:  G X Yan; C Antzelevitch
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

9.  Relation of nausea and vomiting in acute myocardial infarction to location of the infarct.

Authors:  Eileen E Fuller; Rahel Alemu; John F Harper; Mark Feldman
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778

10.  SCN5A mutation associated with acute myocardial infarction.

Authors:  Antonio Oliva; Dan Hu; Sami Viskin; Tabitha Carrier; Jonathan M Cordeiro; Hector Barajas-Martinez; Yusheng Wu; Elena Burashnikov; Ramon Brugada; Rafael Rosso; Alexandra Guerchicoff; Guido Pollevick; Vincenzo L Pascali; Charlie Antzelevitch
Journal:  Leg Med (Tokyo)       Date:  2009-04-02       Impact factor: 1.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.